FBXO28 and hepatocellular carcinoma: Inhibiting PKA activity or mutating PKA putative phosphorylation sites on SNAI2 disrupts the interaction of SNAI2 with FBXO28 and stabilizes the substrate, thereby promoting EMT in HCC.